
    
      The WOEST 2 Registry is a prospective, international, multi-centre, non-interventional,
      cohort study designed to recruit an unselected cohort of patients with atrial fibrillation
      and/or a heart valve prosthesis undergoing coronary revascularisation.

      Trial overview

      Name : WOEST 2 REGISTRY

      Target for enrollment : 2200 patients

      Time frame for inclusion : within 72 hours after index PCI or coronary artery bypass grafting
      (CABG)

      Follow-up : 24 months

      Visits : 30 days, 12 and 24 months after index PCI or CABG
    
  